Summary:
- H.I.G. Capital has recently completed transactions focusing on healthcare services and European market expansion, while also divesting non-core assets from portfolio companies.
- The investment firm added veteran private equity professional Antonin Marcus as a managing director in its Paris office to lead middle market LBO activities in France.
- H.I.G. also acquired ITH Group Limited, a UK provider of aseptic pharmaceutical compounding services, and divested its EBI Bone Healing Division to concentrate resources on core spine solutions and surgical technology innovation.
Unique Article:
H.I.G. Capital, a prominent investment firm based in Miami, has been making significant moves in the healthcare services sector and expanding its presence in the European market. In a series of transactions in June, the company showcased its strategic focus on these key areas while also streamlining its portfolio by divesting non-core assets.
One of the notable developments for H.I.G. Capital was the addition of Antonin Marcus, a seasoned private equity professional, as a managing director in its Paris office. Marcus, who previously worked at H.I.G. and Goldman Sachs, will be leading middle market LBO activities in France, enhancing the firm’s European capabilities.
In addition to strengthening its team, H.I.G. Capital also made a strategic acquisition by purchasing ITH Group Limited, a UK-based provider of aseptic pharmaceutical compounding services. This move aligns with the company’s commitment to investing in healthcare services, particularly in undersupplied market segments such as chemotherapy and total parenteral nutrition.
Furthermore, H.I.G. Capital divested its EBI Bone Healing Division to Avista Healthcare Partners, allowing its portfolio company Highridge Medical to focus on core spine solutions and surgical technology innovation. This strategic decision reflects H.I.G.’s commitment to optimizing its portfolio and driving growth in key areas of the healthcare sector.
Overall, H.I.G. Capital continues to demonstrate its expertise and strategic vision in the investment landscape, with a strong focus on healthcare services, European market expansion, and portfolio optimization. With a track record of successful transactions and a global presence, the firm remains a key player in the alternative investment space.
